Author

Abdurrahman Işıkdoğan

Institutions: Dicle University, Dicle Üniversitesi Hastaneleri

Observed institutions: Dicle University, Dicle Üniversitesi Hastaneleri

ORCID: 0000-0002-7451-7286

Observed ORCID: 0000-0002-7451-7286

OpenAlex ID: A5122137160

Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry

2026 · Dilek Tatlıdede, Çağatay Arslan, et al. · Anadolu Kliniği Tıp Bilimleri Dergisi · 1

Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

2026 · İlker Nihat Ökten, Tuba Baydaş, et al. · Journal of Clinical Medicine · 1

Comparison of Tailor X and NSABP-20 regarding cost-effectiveness of recurrence score (RS®) for adjuvant chemotherapy decision in early-stage breast cancer

2026 · Çetin Ordu, Enver Özkurt, et al. · BMC Health Services Research

Works count: 3

Citation count: 2

H-index: 1

I10-index: